Catalog name Description price
R-M-1281 Boc-MLF Peptide,Cas:67247-12-5 Boc-MLF is an antagonist of the formyl peptide receptor 1 (FPR1) that reduces superoxide production induced by fMLF with an EC50 of 63 uM. Boc-MLF blocks fMLF-stimulated primary granule exocytosis. price>
R-M-1282 Boc-FLFLF Peptide Boc-FLFLF is an antagonist that preferentially inhibit activity triggered through the formyl peptide receptor (FPR). price>
R-M-1307 Leucomyosuppressin Peptide,Cas:106884-19-9 Leucomyosuppressin is a peptide found in arthropods that exhibits anorexigenic and cardiomodulatory activity. Leucomyosuppressin decreases food intake and weight gain as well as heart rate in vivo. Additionally, leucomyosuppressin is myoinhibitory, inhibiting phasic activity and peristalsis in many muscles. price>
R-M-1328 HIV Integrase Protein Inhibitor Peptide,CAS:172546-75-7 HIV Integrase Protein Inhibitor Peptide is a Inhibits HIV integrase. price>
R-M-1345 Glucagon [19-29],Cas:64790-15-4 Glucagon [19-29] corresponds to the C-terminal fragment of glucagon, a hormone secreted in the A cells of the islets of Langherans that plays a key role in glucose metabolism and homeostasis. Glucagon [19-29] is a potent Ca2+/Mg2+-ATPase inhibitor. It inhibits secretagogue-induced insulin secretion in beta-cells (IC50<1 pM) and Ca2+/Mg2+-ATPase activity in liver plasma membranes (IC50=0.75 nM). It also contributes to the positive inotropic effect of glucagon in cardiac cells by amplifying the cytosolic Ca2+ signal. price>
R-M-1370 Fibrinolysis Inhibiting Factor Peptide Fibrinolysis inhibiting factor corresponds to the N-terminal end of alpha chain of fibrin increasing fibrinogen resistance to plasmin. price>
R-M-1382 ENF(T-20) Peptide,Cas:159519-65-0 Enfuvirtide is an envelope fusion inhibitor used to treat HIV-infected patients. The peptide binds to the HIV envelope glycoprotein gp41 and prevents viral fusion with the target cell membrane. Enfuvirtide (Fuzeon/Roche) was approved by the FDA in 2003. price>
R-M-1410 Chromostatin Peptide (Bovine) Chromostatin completely inhibits catecholamine release from chromaffin cells. price>
R-M-1435 BNP 32 Peptide (Rat),Cas:133448-20-1 Brain natriuretic peptide 32 (BNP-32) act as a cardiac hormone with a variety of biological actions including natriuresis, diuresis, vasorelaxation, and inhibition of renin and aldosterone secretion. BNP-32 is used to treat heart failure (Nesiritide, Scios). price>
R-M-1475 RENIN INHIBITOR PEPTIDE,CAS : 50410-01-0 Renin inhibitor peptides (RIPs) exhibit antihypertensive activity in vivo; RIPs with sequences similar to this peptide decrease blood pressure and plasma angiotensin II in animal models without affecting angiotensin converting enzyme activity. price>